MAMohamad J. Alshikho

Mohamad J. Alshikho

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Mohamad J. Alshikho has a total of 50 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Alzheimer Disease, Vascular Disease, and Blood-Brain Barrier Permeability Biomarkers in Middle-Aged Adults

    by Natalie C. Edwards, Patrick Lao, Mohamad J. Alshikho, Jessica Mazen, Benjamin Huber, Christiane Hale, Joncarlos Berroa, Natalie Morel, Alicia Pacheco, Sara Walker, et al.

    Cerebrovascular disease (CVD) influences Alzheimer disease (AD) risk and progression, but the link between vascular disease and AD pathophysiology remains unclear, particularly in midlife when the impact of CVD on AD risk may be strongest. This study examined the relationship of recently validated vascular cognitive impairment (VCI) plasma biomarker concentrations that reflect aspects of blood-brain barrier dysfunction with MRI markers of CVD and AD plasma biomarker concentrations. The study included middle-aged participants from the Offspring Study of Racial and Ethnic Disparities in AD who had MRI and plasma biomarker data available. Biomarker concentrations of vascular endothelial growth factor (VEGF) family members (VEGF-D, placental growth factor [PlGF], and basic fibroblast growth factor [bFGF]) were measured using the Meso Scale Discovery platform. β-Amyloid (Aβ42, Aβ40), phosphorylated tau 181 (p-tau181), astrocytosis (glial fibrillary acidic protein [GFAP]), and neurodegeneration (neurofilament light chain [NfL]) biomarkers were measured with Simoa immunoassays. White matter hyperintensity (WMH) volumes were derived from T2-weighted MRI scans. Bivariate relationships of WMH, Aβ42/Aβ40 ratio, p-tau181, GFAP, and NfL with VEGF biomarkers were tested, and path analyses examined potential causal pathways linking each VEGF biomarker concentration to WMH and GFAP, as well as their downstream associations with tau pathology and neurodegeneration. We analyzed data from 488 participants (mean [SD] age = 54.3 [10.5]; 66.8% women). Higher PlGF levels were associated with older age (R [CI] = 0.25 [0.17-0.33]); greater WMH volume (R [CI] = 0.2 [0.11-0.29]); and higher levels of GFAP (R [CI] = 0.11 [0.02-0.2]), p-tau181 (R [CI] = 0.12 [0.03-0.21]), and NfL (R [CI] = 0.19 [0.1-0.27]). Higher VEGF-D was associated with increased GFAP (R [CI] = 0.11 [0.02-0.19]) and NfL (R [CI] = 0.16 [0.07-0.25]) levels. bFGF concentration was associated with a lower Aβ42/40 ratio (R [CI] = -0.1 [-0.19 to -0.02]) and higher p-tau181 levels (R [CI] = 0.13 [0.04-0.21]). The best fitting path model showed that PlGF had an indirect effect on GFAP levels mediated by WMH. GFAP subsequently had a direct positive effect on p-tau181, which in turn had a positive effect on NfL levels. VEGF-D and bFGF levels also had a positive direct effect on NfL. The findings suggest that permeability of the blood-brain barrier is linked to AD pathophysiology, contributes to cerebrovascular lesions observed on MRI, and is associated with neuroinflammation in middle age.


  • Integrated magnetic resonance imaging and [11C]‐PBR28 positron emission tomographic imaging in amyotrophic lateral sclerosis

    by Mohamad J. Alshikho, Nicole R. Zürcher, Marco L. Loggia, Paul Cernasov, Beverly Reynolds, Olivia Pijanowski, Daniel B. Chonde, David Izquierdo Garcia, Caterina Mainero, Ciprian Catana, et al.

    Objective: To characterize [11C]‐PBR28 brain uptake using positron emission tomography (PET) in people with amyotrophic lateral sclerosis (ALS) and primary lateral sclerosis (PLS). We have previously shown increased [11C]‐PBR28 uptake in the precentral gyrus in a small group of ALS patients. Herein, we confirm our initial finding, study the longitudinal changes, and characterize the gray versus white matter distribution of [11C]‐PBR28 uptake in a larger cohort of patients with ALS and PLS.Methods: Eighty‐five participants including 53 with ALS, 11 with PLS, and 21 healthy controls underwent integrated [11C]‐PBR28 PET–magnetic resonance brain imaging. Patients were clinically assessed using the Upper Motor Neuron Burden (UMNB) and the Amyotrophic Lateral Sclerosis Functional Rating Scale–Revised (ALSFRS‐R). [11C]‐PBR28 uptake was quantified as standardized uptake value ratio (SUVR) and compared between groups. Cortical thickness and fractional anisotropy were compared between groups and correlated with SUVR and the clinical data. [11C]‐PBR28 uptake and ALSFRS‐R were compared longitudinally over 6 months in 10 ALS individuals.Results: Whole brain voxelwise, surface‐based, and region of interest analyses revealed increased [11C]‐PBR28 uptake in the precentral and paracentral gyri in ALS, and in the subcortical white matter for the same regions in PLS, compared to controls. The increase in [11C]‐PBR28 uptake colocalized and correlated with cortical thinning, reduced fractional anisotropy, and increased mean diffusivity, and correlated with higher UMNB score. No significant changes were detected in [11C]‐PBR28 uptake over 6 months despite clinical progression.Interpretation: Glial activation measured by in vivo [11C]‐PBR28 PET is increased in pathologically relevant regions in people with ALS and correlates with clinical measures. Ann Neurol 2018;83:1186–1197


  • Open Access

    Integrated imaging of [11C]-PBR28 PET, MR diffusion and magnetic resonance spectroscopy 1H-MRS in amyotrophic lateral sclerosis

    by Eva-Maria Ratai, Mohamad J. Alshikho, Nicole R. Zürcher, Marco L. Loggia, Catherine L. Cebulla, Paul Cernasov, Beverly Reynolds, Jennifer Fish, Raghav Seth, Suma Babu, et al.


  • Open Access

    Imaging of glia activation in people with primary lateral sclerosis

    by Sabrina Paganoni, Mohamad J. Alshikho, Nicole R. Zürcher, Paul Cernasov, Suma Babu, Marco L. Loggia, James Chan, Daniel B. Chonde, David Izquierdo Garcia, Ciprian Catana, et al.


  • Correlation of Fractional Anisotropy With Motor Recovery in Patients With Stroke After Postacute Rehabilitation

    by Hongmei Wen, Mohamad J. Alshikho, Yao Wang, Xun Luo, Ross Zafonte, Martha R. Herbert, Qing Mei Wang


  • Open Access

    Intestinal Lymphangiectasia: Insights on Management and Literature Review

    by Mohamad J. Alshikho, Joud M. Talas, Salem I. Noureldine, Saf Zazou, Aladdin Addas, Haitham Kurabi, Mahmoud Nasser

    BACKGROUND:Intestinal lymphangiectasia (IL) is a rare disease characterized by a dilatation of the intestinal lymphatics and loss of lymph fluid into the gastrointestinal tract leading to hypoproteinemia, edema, lymphocytopenia, hypogammaglobinemia, ...


  • Open Access

    Zollinger-Ellison Syndrome Associated with von Recklinghausen Disease: Case Report and Literature Review

    by Mohamad J. Alshikho, Salem I. Noureldine, Joud M. Talas, Antoine Nasimian, Safi Zazou, Bashir Mobaed, Mahmoud Nasser

    BACKGROUND:Pancreatic endocrine tumors (PETs) are rare and can occur as part of neurofibromatosis type 1 (NF1). Gastrinomas are functional PETs that are rarely associated with NF1. Only two cases of their occurrence have been reported in the literatu...